KURA
Kura Oncology, Inc.
NASDAQ · USHealthcareBiotechnology
$10.68-1.66%
Price as of Jul 20, 2026
KURA valuation
Kura Oncology, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 13.85x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 8.79x
- Price / sales
- 13.23x
- Price / cash flow
- -12.16x
Enterprise value
- Enterprise value
- $391.6M
- EV / sales
- 5.47x
- EV / EBITDA
- -1.34x
- EV / EBIT
- -1.23x
- Market cap
- $948.1M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.